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SUMMARY
Bone extracellular matrix proteins osteopontin and osteonectin have important function dur-
ing embryonic osteogenesis and are active in bone remodeling process. Knowledge about bone
extracellular matrix proteins explores the mechanisms of craniofacial development and helps to
understand better morphopathogenesis of severe dentofacial anomalies. Aim of the current study
was to investigate an expression of osteopontin and osteocalcin in maxilla tissue in skeletal Class
III patients.
The study group included 10 skeletal Class III patients to whom combined orthodontic and
surgical treatment was recommended. Samples of tuber maxillae tissue from ten skeletal Class
III malocclusion patients were collected due the orthognatic surgery procedure. The routine histo-
logical method was followed and samples were stained by hematoxyline-eosine. Tissue samples
were stained according the standard immunohistochemical methods and expression of osteocalcin
and osteopontin in maxilla tissue was examined. Distribution of these factors was evaluated
semiquantitetively by counting the positive structures in visual field.
The trabecules of bone contained parallel located collagen fibers and irregular bone mineral-
ization.  Connective tissue proliferation in osteon channels was observed. Quantity of cells posi-
tive to osteopontin was higher than quantity of cells containing osteocalcin in all patterns extracted
of maxilla tissue in patients with skeletal Class III.
In few cases osteocalcin positive cells were located near the border with soft tissue – close
to osteogenic cells zone, but no osteocalcin was observed deeper in bone. The intensity of
osteocalcin expression was variable, and differs individually despite the relatively regular osteopontin
distribution in all patterns.
There were pronounced osteopontin, but not osteocalcin-containing cells with approximately
similar intensity of protein expression in tuber maxillae in skeletal Class III patients.
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INTRODUCTION
Craniofacial skeletal development and growth
is a complex and strongly controlled process. Cran-
iofacial growth is an issue of the great importance
in orthodontic scientific researches for long time-
period, and several theories of craniofacial growth
were postulated (remodeling theory, suture theory,
the nasal septum theory, functional matrix hypoth-
esis, servosystem theory) [1, 2, 3, 4, 5]. Knowledge
about a cartilage and a bone is based on anatomi-
cal, endocrinological, and cellular studies, but im-
portance of the specific growth and differentiation
factors, extracellular matrix proteins, signaling me-
diators, and transcription factors in bone develop-
ment were documented in latest molecular and bio-
logical studies.
Noncollagenous matrix proteins have a great
importance in regulating of ossification and bone
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remodeling. Osteopontin is a multifunctional phos-
phorylated glycoprotein secreted by osteoblasts, and
has been suggested to occur at an early stage dur-
ing bone development and to promote attachment
of osteoblasts to the extracellular matrix [6]. In
normal bone tissue, osteopontin is expressed by
osteoclasts and osteoblasts, and thereby is involved
in bone remodeling [7]. Rodents deficient in
osteopontin has an impact on wound healing, char-
acterized by normal wound strength but abnormal
maturation of collagen fibers [8]. Protein is highly
expressed in bone, and also expressed by various
cell types including macrophages, endothelial cells,
smooth muscle cells and epithelial cells [7].
Gravallase EM [9] has investigated the role of
osteopontin in connection between the immune sys-
tem and bone.
Osteocalcin is a marker of bone formation, vi-
tamin K and vitamin D dependant protein, produced
by osteoblasts [10]. Although the actual function of
osteocalcin is still unexplored, it may be involved in
the regulation of mineralization, and its serum con-
centrations correlate with histomorphometric indi-
ces of newly formed bone [11, 12].
Bone extracellular matrix proteins – i.e.
osteopontin and osteonectin – have important func-
tion during embryonic osteogenesis and are active
in bone remodeling process. Knowledge about bone
extracellular matrix proteins explores the mecha-
nisms of craniofacial development and helps to un-
derstand better morphopathogenesis of severe
dentofacial anomalies.
According to McNamara and co-authors [13]
about 47% of individuals with Class III malocclu-
sion had a retrusive position of maxilla and about
42% had some degree of mandibulae prognathism,
therefore it is important to understand also the role
of maxilla in skeletal Class III malocclusion.
Aim of the current study was to investigate an
expression of osteopontin and osteocalcin in maxilla
tissue in skeletal Class III patients.
MATERIALS AND METHODS
The study group included 10 skeletal Class III
patients to whom combined orthodontic and surgi-
cal treatment was recommended. From them: 4
male and 6 female, at 19.4 years of age in aver-
age.  Patients with skeletal asymmetries, dentofacial
syndromes, cleft lip and palate were not included
in the study. Orthognathic surgery in the same
technique was performed by three surgeons in Riga
Stradins University Institute of Stomatology, De-
partment of Oral and Maxillofacial Surgery. Tis-
sue samples from tuber maxillae were collected
due the orthognatic surgery procedure as tuber
maxillae is considered as one of the main growing
centers in upper jaw. The tissue samples were
fixed in 2% formaldehyde and 0.2% picric acid
0.1 M phosphate – buffer (pH 7.2). Histological
investigation was performed at the Riga Stradins
University Institute of Anatomy and Anthropology.
Fixed tissue samples were washed in phosphate-
buffered saline for 12 hours, embedded in paraffin
and cut into into 6-7mm thick sections. After
deparafinization osteopontin and osteocalcin expres-
sion in tissue patterns was examined by the biotin-
streptavadin immunohistochemistry (IMH) [14].
The routine histological method with hematoxyline-
eosine staining was used. Appearance of positive
factors was detected semiquantitatively by count-
ing of positive structures in visual field (0/- - oc-
casional, + - few, ++ - moderate, +++ - numerous,
++++ - abundance positive structures in visual field
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Fig. 1. Microphotograph of bone from tuber maxillae
(haematoxylin and eosine; x250). Irregular distribution of
osteone structures.
Fig. 2. Microphotograph of bone from tuber maxillae
(haematoxylin and eosine; x 250). Chaotically organized bone
structure.
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[15]. The study protocol for work with human
originated material was approved by Ethical Com-
mittee of Riga Stradins University.
RESULTS
The trabecules of bone contained mainly paral-
lel located collagen fibers and connective tissue pro-
liferation in osteon channels was observed. The signs
of sclerotization in soft tissue blood vessels close to
bone fragments were determined (see Fig. 1, Fig.
2).
Tissue extracted from tuber maxillae in
orthognatic Class III patients  demonstrated inten-
sively expressed, positive cells to osteopontin (++/
+++; see Fig. 3, Fig. 4) and the distribution of this
bone extracellular matrix protein was relatively regu-
lar. Osteopontin expressed by tuber maxillae os-
teocytes was determined in osteogenic and peri-
osteal cells.
The expression of osteocalcin was very het-
erogeneous. Some specimens have no of osteocalcin
positive cells (Fig. 5), and abundant in the other
(Fig. 6).
In some cases osteocalcin positive cells were
located near the border with soft tissue – close to
osteogenic cells zone, but osteocalcin was not de-
termined – containing osteocyts deeper in bone.
The intensity of osteocalcin expression was vari-
able, and differs individually, however distribution
of osteopontin in all patterns were relatively regu-
lar (see Table). There was no difference in
osteopontin and osteocalcin expression between
genders.
DISCUSSION
Noncollagenous extracellular bone matrix pro-
teins have importance in bone turnover during em-
bryogenesis and later (and due the life-time), but
their expression in matured human bone is not well
defined. In present study osteopontin was the most
dominant noncollagenous extracellular bone matrix
protein. Osteopontin is to be an early marker of
bone matrix, but osteocalcin – late marker [16].
Sasano et al. [6] suggested that bone matrix pro-
teins continue to accumulate in the matrix as em-
bryonic osteogenesis proceeds and bone expands
its area with more intense osteopontin deposition as
the periphery of bone, which consists of immature
matrix components, but less intensive presence of
protein in the central parts of bone that is more
matured. This data corresponds to findings in cur-
rent study, as osteopontin expression was relatively
regular through bone with increased staining near
periosteum.
Osteocalcin is produced by mature osteoblasts,
odontoblasts and chondrocytes. Ducy et al. [17] in
his study with the osteocalcin knockout mice re-
ported no abnormal phenotype until 6 months of age
because there was marked higher bone mass and
Table. Expression of osteocalcin and osteopontin in bone
from tuber maxillae in Class III patients
Number of patients Osteokalcin Osteopontin 
1. ++++ + 
2. ++++ +++ 
3. 0/+ + 
4. +++ +++ 
5. 0/+ ++ 
6. +/++ + 
7. 0/+ + 
8. +++ ++/+++ 
9. 0/+ ++ 
10. +++ ++ 
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CFig. 3. Microphotograph of osteopontin expression in bonefrom tuber maxillae in Class III  patient, IH, x200
Fig. 4. Microphotograph of osteopontin expression in bone
from tuber maxillae in Class III  patient, IH, x200
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bones of improved functional quality. Another find-
ing of Ducy et al. was the determination of the
increase in osteoclast number possibly indicating the
poor osteoclasts functioning in mutant mice. Find-
ings of current study demonstrated very inconsis-
tent expression of osteocalcin in bone from tuber
maxillae in Class III patients, and this corresponds
with clinical signs of patients, because they have
excess of mandibular growth and/or normal maxil-
lary growth, suggesting that there could be some
disturbances in osteocalcin-depending bone remod-
eling.
C
Fig. 5. Microphotograph of osteocalcin expression in bone
from tuber maxillae in Class III patient, IH, x200
Fig. 2. Microphotograph of osteocalcin expression in bone
from tuber maxillae in Class III  patient, IH, x200
Further immunohistochemical investigation on
osteocalcin and osteopontin expression helps to un-
derstand better their role in skeletal Class III growth
pattern and comparison with normal craniofacial
growth pattern is necessary.
CONCLUSION
Skeletal Class III patients demonstrate pro-
nounced osteopontin, but not osteocalcin-containing
cells in tuber maxillae with approximately similar
intensity in protein expression.
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